We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

49 hedge funds and large institutions have $68.5M invested in Marrone Bio Innovations, Inc. in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $69.1M → $68.5M (-$596K)

8% less funds holding

Funds holding: 53 → 49 (-4)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

38% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 16

Holders
49
Holders Change
-4
Holders Change %
-7.55%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
16
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EIM
Essex Investment Management
Massachusetts
+$868K
2
N
Nuveen
North Carolina
+$198K
3
FC
Fairpointe Capital
Illinois
+$155K
4
Millennium Management
Millennium Management
New York
+$92.3K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$92.1K

Top Sellers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
-$215K
2
State Street
State Street
Massachusetts
-$54.6K
3
ECM
ExodusPoint Capital Management
New York
-$49K
4
SIM
Spark Investment Management
New York
-$43.8K
5
Deutsche Bank
Deutsche Bank
Germany
-$38.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
51
Marco Investment Management
Georgia
– -$23K -15,000 Closed
WIC
52
Whitegate Investment Counselors
New Hampshire
– -$23K -15,000 Closed
PPA
53
Parametric Portfolio Associates
Washington
– -$20K -12,792 Closed
OAM
54
Oxford Asset Management
United Kingdom
– -$18K -11,642 Closed
VF
55
Virtu Financial
New York
– -$16K -10,716 Closed
PP
56
Paloma Partners
Connecticut
– -$16K -10,494 Closed
TRCT
57
Tower Research Capital (TRC)
New York
– -$12K -8,247 Closed
OWD
58
Osborn Williams & Donohoe
Ohio
– -$4K -2,500 Closed
1 2
3

MBII Hedge Fund Activity: Q2 2019 in Review

49 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2019, worth a combined $68.5M — down 0.86% from $69.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of MBII and 7 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 10 added.

The largest buyer was Essex Investment Management, opening a new position worth an estimated $868K. The largest seller was Primecap Management, cutting an estimated $215K.

  • 49 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2019, down from 53 in Q1 2019.
  • Funds reported $68.5M of Marrone Bio Innovations, Inc. stock for Q2 2019, down 0.86% quarter-over-quarter.
  • 7 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2019 and 9 closed out, a net change of -2 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q2 2019 was Essex Investment Management, an estimated $868K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q2 2019 was Primecap Management, an estimated $215K sold.

Based on aggregated 13F filings for Q2 2019.